Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ropivacaine liposomal - Taiwan Liposome Company

Next Previous
X
Search
Drug Profile

Ropivacaine liposomal - Taiwan Liposome Company

Alternative Names: TLC-590

Latest Information Update: 30 Aug 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Taiwan Liposome Company
  • Class Amides; Anilides; Local anaesthetics; Non-opioid analgesics; Piperidines; Small molecules
  • Mechanism of Action Potassium channel antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Postoperative pain

Most Recent Events

  • 27 Aug 2024 Taiwan Liposome Company plans a phase II trial for post-operative pain in the US (Controlled release) (NCT06574269)
  • 11 Jun 2021 Taiwan Liposome company plans pivotal phase III trial in postoperative pain in the second half of 2021
  • 14 May 2021 Taiwan Liposome Company planning end-of-phase-II meetings with the United States Food and Drug Administration (FDA) on the design of the clinical trials and production preparations in June 2021

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top